Tysabri - 2/7 - Xconomy

Entry	Author	Date	Location
Avila Therapeutics Hires First CEO Katrine Bosley, Adds $5M from Existing Investors	Ryan McBride	05/15/09	Boston
Biogen Idec Pipeline Strong, Tysabri Coming Back; Icahn Would “Weaken” Board, Company Says	Luke Timmerman	05/14/09	Boston
Taligen Raises $26M For Inflammation Drugs	Luke Timmerman	05/12/09	Boston
Icahn Throws Down the Gauntlet, Attacks Biogen Idec’s “Failed Leadership”	Luke Timmerman	05/11/09	Boston
Tysabri May Promote Healing Around Nerves, Study Says	Luke Timmerman	04/28/09	Boston
Biogen Idec To Show Off MS Drugs at Seattle Neurology Meeting	Luke Timmerman	04/24/09	Boston
Biogen Idec Tysabri Sales Fall Shy of Street Expectations	Luke Timmerman	04/16/09	Boston
FDA Allows High-Yield Tysabri Production	Ryan McBride	04/16/09	Boston
Rematch Time: Carl Icahn and Biogen Idec Square Off Again	Luke Timmerman	04/14/09	Boston
Carl Icahn Aims to Stick “For Sale” Sign on Biogen Idec Lawn Again	Luke Timmerman	02/06/09	Boston
Biogen Idec Rival Succeeds in Trial of Oral Pill for Multiple Sclerosis	Luke Timmerman	01/23/09	Boston
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked)	Gregory T. Huang	12/31/08	Seattle
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News	Wade Roush	12/24/08	Boston
Tysabri Patient Dies of Brain Infection, First Death Since Drug Re-Introduced	Luke Timmerman	12/19/08	Boston
Tysabri Patient Diagnosed With PML	Luke Timmerman	12/15/08	Boston
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms	Ryan McBride	12/12/08	San Diego
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News	Luke Timmerman	11/06/08	Seattle
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News	Rebecca Zacks	11/05/08	Boston
Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch”	Luke Timmerman	11/04/08	Seattle
Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri	Luke Timmerman	10/31/08	Boston
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection	Luke Timmerman	10/29/08	Boston
Dying Cancer Patient Gets Tysabri After Biogen Idec’s Earlier Denial	Luke Timmerman	10/16/08	Boston
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why	Luke Timmerman	10/14/08	Boston
Biogen Idec, Elan Start First Cancer Trial With Tysabri	Luke Timmerman	09/05/08	Boston
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis	Luke Timmerman	08/27/08	Boston
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling	Luke Timmerman	08/26/08	Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Icahn Ups Biogen Idec Stake to 6 Percent—Bought Big on Tysabri Woes	Ryan McBride	08/12/08	Boston
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News	Rebecca Zacks	08/06/08	Boston
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri	Luke Timmerman	08/01/08	Boston
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Avila Therapeutics Hires First CEO Katrine Bosley, Adds $5M from Existing Investors

Ryan McBride

05/15/09

Boston

Biogen Idec Pipeline Strong, Tysabri Coming Back; Icahn Would “Weaken” Board, Company Says

Luke Timmerman

05/14/09

Boston